Showing results (71-80 of 198) with videos related to
Sort By:
Pageof 20
Journal of Immunology (Baltimore, Md. : 1950)|January 13, 2022
Fewer LAG-3<sup>+</sup> T Cells in Relapsing-Remitting Multiple Sclerosis and Type 1 DiabetesBritta E Jones, Megan D Maerz, Henry T Bahnson, et al.Arthritis and Rheumatism|March 7, 2012
Multifunctional T cell reactivity with native and glycosylated type II collagen in rheumatoid arthritisOmri Snir, Johan Bäcklund, Julia Boström, et al.Biorxiv : the Preprint Server for Biology|May 25, 2026
Deep immune profiling of the peripheral blood reveals disease- and sex-associated immune cell signatures in patients with systemic sclerosisNikhil Jiwrajka, Florin Tuluc, Nuriban Valero-Pacheco, et al.Scandinavian Journal of Immunology|December 10, 2013
Peripheral and site-specific CD4(+) CD28(null) T cells from rheumatoid arthritis patients show distinct characteristicsJ Pieper, S Johansson, O Snir, et al.Arthritis and Rheumatism|May 14, 2011
Identification and functional characterization of T cells reactive to citrullinated vimentin in HLA-DRB1*0401-positive humanized mice and rheumatoid arthritis patientsOmri Snir, Mary Rieck, John A Gebe, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 2, 2013
Cutting Edge: a novel, human-specific interacting protein couples FOXP3 to a chromatin-remodeling complex that contains KAP1/TRIM28Chunjian Huang, Sunil Martin, Christian Pfleger, et al.The Journal of Clinical Investigation|November 5, 2003
Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cellsMindi R Walker, Deborah J Kasprowicz, Vivian H Gersuk, et al.Clinical Immunology (Orlando, Fla.)|May 30, 2018
Circulating integrin alpha4/beta7+ lymphocytes targeted by vedolizumab have a pro-inflammatory phenotypeJames D Lord, S Alice Long, Donna M Shows, et al.Plos Pathogens|September 26, 2007
T cells contain an RNase-insensitive inhibitor of APOBEC3G deaminase activityBeth K Thielen, Kevin C Klein, Lorne W Walker, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 10, 2007
Cutting edge: high molecular weight hyaluronan promotes the suppressive effects of CD4+CD25+ regulatory T cellsPaul L Bollyky, James D Lord, Susan A Masewicz, et al.Pageof 20